Management of cardiopulmonary bypass in factor XII deficient patients without plasma infusion
- 17 September 2021
- journal article
- letter
- Published by SAGE Publications in Perfusion
- Vol. 37 (3) , 323-325
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Evaluation of Point-of-Care ACT Coagulometers and Anti-Xa Activity During Cardiopulmonary BypassJournal of Cardiothoracic and Vascular Anesthesia, 2020
- Global cerebral infarction after aortic arch replacement surgery in a patient with postoperatively revealed factor XII deficiency: a case reportJournal of Medical Case Reports, 2020
- Adverse effects of plasma transfusionTransfusion, 2012
- Factor XII stimulates ERK1/2 and Akt through uPAR, integrins, and the EGFR to initiate angiogenesisBlood, 2010
- Contact factor deficiencies and cardiopulmonary bypass surgery: detection of the defect and monitoring of heparinEuropean Journal of Haematology, 2009
- Laboratory Monitoring of Heparin Therapy: Partial Thromboplastin Time or Anti-Xa Assay?Laboratory Medicine, 2009
- Factor XII deficiency and cardiopulmonary bypassPerfusion, 1995
- Congenital factor XII deficiency and cardiopulmonary bypassThe Annals of Thoracic Surgery, 1994